- Home
- MNPR vs LOCO Comparison
MNPR vs LOCO Comparison
Compare MNPR & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | LOCO |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.9M | 411.3M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MNPR | LOCO |
|---|---|---|
| Price | $58.91 | $13.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $107.00 | $14.17 |
| AVG Volume (30 Days) | 160.0K | ★ 267.5K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.99 | 4.65 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $401,701,000.00 |
| Revenue This Year | N/A | $3.60 |
| Revenue Next Year | N/A | $3.98 |
| P/E Ratio | ★ N/A | $49.85 |
| Revenue Growth | N/A | ★ 5.68 |
| 52 Week Low | $28.40 | $8.87 |
| 52 Week High | $105.00 | $15.90 |
Technical Indicators
Market Signals| Indicator | MNPR | LOCO |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 48.84 |
| Support Level | $50.60 | $13.42 |
| Resistance Level | $61.51 | $14.38 |
| Average True Range (ATR) | 4.38 | 0.53 |
| MACD | 0.47 | -0.03 |
| Stochastic Oscillator | 51.18 | 24.50 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.